Rare and Orphan Diseases - Global Neurology Academy

Episodes 1-16 of 39

How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiers
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
- John A. Morren, MD, FAAN, FAANEM
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiers
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiers
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Debunking gMG Myths: Counseling Strategies That Change the Conversation
Debunking gMG Myths: Counseling Strategies That Change the Conversation
NeuroFrontiers
Debunking gMG Myths: Counseling Strategies That Change the Conversation
- Maxwell H. Levy, MD
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiers
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
- Maxwell H. Levy, MD
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiers
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
- Rosaline Quinlivan
- Ryan Quigley
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiers
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
- Rosaline Quinlivan
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiers
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
- Rosaline Quinlivan
The Complexities of DMD: Optimizing Multidisciplinary Care
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiers
The Complexities of DMD: Optimizing Multidisciplinary Care
- Rosaline Quinlivan
Reducing the Burden of gMG with a Novel B-Cell Therapy
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiers
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
- Richard Nowak, MD, MS
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
NeuroFrontiers
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
- Charles Turck, PharmD, BCPS, BCCCP
- Jason Ackrivo, MD, MSCE
- Bethany Lussier, MD
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
- Jennie Taylor, MD
mIDH Gliomas Explained: Characteristics and Management Strategies
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
- Jennie Taylor, MD

Prev
1
2
3
Next

1/3